Bladder cancer has earned the title as the "forgotten cancer" despite being the fifth most common in Canada. According to the Canadian Cancer Society, it's estimated that in 2024, 12,300 Canadians ...

The acidity may also trigger symptoms in people with interstitial cystitis, which causes pain and a feeling of pressure around the bladder. Additionally, juice contains a lot of sugar, which can ...

But few of us think about how what we eat and drink impacts our bladders. Although there’s no dietary ‘cure’ for a weak or irritated bladder, eating food and drink that support your urinary health – ...

Keeping its bladder clean, dry and mold-free between uses! That's where the DRYE device comes in, as it's a battery-powered fan designed specifically to dry hydration pack bladders. SUBSCRIBE ...

If you have bladder cancer, there are several treatment options. Your doctor will help you decide which one is best for you. Choosing the best treatment depends on a number of things ...

If a person frequently needs to pee but little comes out when they try to go, it can be due to a urinary tract infection (UTI), pregnancy, an overactive bladder, or an enlarged prostate.

Holding in urine can cause the bladder to weaken, making it difficult to empty. Doctors refer to this as urinary retention. Urine accumulation increases the risk of bacterial infection in the bladder.

Mark D. Tyson, MD, MPH, discusses cretostimogene and how it varies from other therapies for bladder cancer. Cretostimogene grenadenorepvec is an investigational oncolytic immunotherapy that is being ...

Early findings from Johnson & Johnson’s Phase IIb SunRISe-1 trial show the promise of TAR-200 in patients with Bacillus Calmette-Guérin–unresponsive, high-risk non–muscle-invasive bladder cancer, ...

“Complication rates were super low: just 3.7% for prostate surgeries, 1.9% for kidney surgeries, and 17.9% for bladder surgeries, all beating safety goals from years of research”. The company further ...

Pfizer has linked its PD-1 inhibitor to a 32% reduction in the risk of disease-related events in a phase 3 bladder cancer trial. But the study fell short of a clean sweep of positive outcomes ...

TAR-200 demonstrated high DFS and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer with papillary-only disease. The phase 2b SunRISe-1 study showed over 80% ...